ORLANDO, Fla. - A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non-economic damages (Nancy Guenther, et al. v. Novartis Pharmaceutical Corporation, No. 6:08-456, M.D. Fla., Orlando Div.).